Cardlytics Earnings Calls
| Release date | Nov 05, 2025 |
| EPS estimate | -$0.327 |
| EPS actual | -$1.36 |
| EPS Surprise | -316.32% |
| Revenue estimate | 56.318M |
| Revenue actual | 52.031M |
| Revenue Surprise | -7.61% |
| Release date | Aug 06, 2025 |
| EPS estimate | -$0.390 |
| EPS actual | -$0.176 |
| EPS Surprise | 54.88% |
| Revenue estimate | 64.016M |
| Revenue actual | 63.249M |
| Revenue Surprise | -1.20% |
| Release date | May 07, 2025 |
| EPS estimate | -$0.480 |
| EPS actual | -$0.260 |
| EPS Surprise | 45.83% |
| Revenue estimate | 58.012M |
| Revenue actual | 61.898M |
| Revenue Surprise | 6.70% |
| Release date | Mar 12, 2025 |
| EPS estimate | -$0.470 |
| EPS actual | -$0.306 |
| EPS Surprise | 34.97% |
| Revenue estimate | 63.627M |
| Revenue actual | 73.997M |
| Revenue Surprise | 16.30% |
Last 4 Quarters for Cardlytics
Below you can see how 0LEC.L performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
| Release date | Mar 12, 2025 |
| Price on release | $2.09 |
| EPS estimate | -$0.470 |
| EPS actual | -$0.306 |
| EPS surprise | 34.97% |
| Date | Price |
|---|---|
| Mar 06, 2025 | $2.40 |
| Mar 07, 2025 | $2.21 |
| Mar 10, 2025 | $2.03 |
| Mar 11, 2025 | $1.83 |
| Mar 12, 2025 | $2.09 |
| Mar 13, 2025 | $2.07 |
| Mar 14, 2025 | $2.37 |
| Mar 17, 2025 | $2.36 |
| Mar 18, 2025 | $2.23 |
| 4 days before | -12.92% |
| 4 days after | 6.74% |
| On release day | -0.96% |
| Change in period | -7.05% |
| Release date | May 07, 2025 |
| Price on release | $2.17 |
| EPS estimate | -$0.480 |
| EPS actual | -$0.260 |
| EPS surprise | 45.83% |
| Date | Price |
|---|---|
| May 01, 2025 | $1.49 |
| May 02, 2025 | $1.83 |
| May 05, 2025 | $2.13 |
| May 06, 2025 | $2.13 |
| May 07, 2025 | $2.17 |
| May 08, 2025 | $1.99 |
| May 09, 2025 | $1.87 |
| May 12, 2025 | $2.14 |
| May 13, 2025 | $2.07 |
| 4 days before | 45.64% |
| 4 days after | -4.84% |
| On release day | -8.33% |
| Change in period | 38.59% |
| Release date | Aug 06, 2025 |
| Price on release | $1.73 |
| EPS estimate | -$0.390 |
| EPS actual | -$0.176 |
| EPS surprise | 54.88% |
| Date | Price |
|---|---|
| Jul 31, 2025 | $2.09 |
| Aug 01, 2025 | $1.98 |
| Aug 04, 2025 | $1.95 |
| Aug 05, 2025 | $1.84 |
| Aug 06, 2025 | $1.73 |
| Aug 07, 2025 | $1.29 |
| Aug 08, 2025 | $1.21 |
| Aug 11, 2025 | $1.12 |
| Aug 12, 2025 | $1.19 |
| 4 days before | -17.46% |
| 4 days after | -31.04% |
| On release day | -25.22% |
| Change in period | -43.08% |
| Release date | Nov 05, 2025 |
| Price on release | $1.69 |
| EPS estimate | -$0.327 |
| EPS actual | -$1.36 |
| EPS surprise | -316.32% |
| Date | Price |
|---|---|
| Oct 30, 2025 | $1.96 |
| Oct 31, 2025 | $1.94 |
| Nov 03, 2025 | $1.91 |
| Nov 04, 2025 | $1.77 |
| Nov 05, 2025 | $1.69 |
| Nov 06, 2025 | $1.29 |
| Nov 07, 2025 | $1.44 |
| Nov 10, 2025 | $1.39 |
| Nov 11, 2025 | $1.44 |
| 4 days before | -13.78% |
| 4 days after | -15.09% |
| On release day | -23.70% |
| Change in period | -26.79% |
Cardlytics Earnings Call Transcript Summary of Q3 2025
Key points for investors: Cardlytics reported Q3 2025 billings of $89.2M (down 20.3% YoY) and revenue of $52.0M (down 22.4%). The decline was driven primarily by content restrictions from its largest financial-institution (FI) partner that effectively blocked roughly one-third of expected billings. Despite the headwind, the company retained the majority of advertisers, grew MQUs 21% to 230.3M (driven by new FI partners), and saw ACPU decline 31% to $0.11. Adjusted contribution was $30.0M (down 17.5%) but contribution margin expanded to 57.7% — the highest to date — reflecting a more favorable mix from newer, higher-margin FI partners. Adjusted EBITDA was positive $3.2M (improving $5.0M YoY). The company completed repayment of the remaining $46M of 2020 convertible notes and implemented substantial cost reductions (latest workforce reduction ~30%; total annualized cost savings expected of $26M in 2026 and $50M year-to-date reductions). Q4 guidance: billings $86M–$96M (down ~26% to 17% YoY), revenue $51.1M–$59.1M, adjusted contribution $29M–$35M, and adjusted EBITDA $0.9M–$7.9M; management expects adjusted EBITDA to be positive for Q4 and the full year. Strategic priorities: diversify and increase supply (Cardlytics Rewards Platform / CRP, new publisher deals including OpenTable), shift volume to other FIs, deepen consumer engagement (category-level offers, Double Days), expand UK growth (22% revenue growth YoY), and continue to invest in measurement and geo-targeting capabilities. Risks and near-term headwinds stem from the largest FI partner’s restrictions and resulting pressure on billings and ACPU; management is not assuming material CRP revenue in 2025 and is prioritizing margin preservation and return to profitable growth.
Sign In
Buy 0LEC